Qin, F., Yu, H., Xu, C., Chen, H., & Bai, J. (2018). Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: A meta-analysis. J Biomed Res.
Citação norma ChicagoQin, Fei, Hao Yu, Chang-Rong Xu, Hui-Hui Chen, and Jian-Ling Bai. "Safety of Axitinib and Sorafenib Monotherapy for Patients With Renal Cell Carcinoma: A Meta-analysis." J Biomed Res 2018.
MLA citiranjeQin, Fei, et al. "Safety of Axitinib and Sorafenib Monotherapy for Patients With Renal Cell Carcinoma: A Meta-analysis." J Biomed Res 2018.
Opozorilo: Ti citati niso vedno 100% točni.